Alvotech SA at Morgan Stanley Sustainable Finance Summit Transcript
Good morning and good afternoon, everyone. My name is Thibault Boutherin. I'm part of the European pharma team, and I am joined on this call by my colleague, Mike Canfield, Head of EMEA Sustainability Research at Morgan Stanley. Please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley's employees only. This webcast is not for members of the press. If you are a member of the press, please disconnect and reach out separately. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures.
We are pleased to have with us Ming Li, Chief Strategy Officer at Alvotech for this session on affordable biologics. Ming, thank you for joining us.
Questions & Answers
And before we get into the details of Alvotech's ESG strategy
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |